Fina Lladós is the Amgen Iberia General Manager since September 2017 and a member of the company's management committee since 2009. She holds a degree in Pharmacy from the University of Barcelona, a Management Development Program from IESE, a postgraduate degree in Industrial Medicine from the UAB, and a Master's Degree in the Pharmaceutical Industry from CESIF. Fina has developed a professional career of more than twenty-five years in the pharmaceutical industry. After her job in Roche and Sanofi-Aventis, she joined Amgen. Over these 20 years in Amgen she has worked in Spain and Switzerland, where the company has its European headquarters. Fina has held various positions of responsibility at Amgen in the R&D, medical and commercial areas and in different therapeutic areas ranging from Clinical Development in early stages, to leadership positions in the Medical Department, as well as Business Directions in different areas before her role as a General Manager. She currently sits on the Board of Directors of Farmaindustria, of which she is also a member of its Governing Council, and currently holds one of the Vice Presidencies of LAWG. Moreover, she is a member of the Board of Directors of the U.S. Chamber of Commerce in Spain.